Literature DB >> 27704250

Regulatory T Cells in SLE: Biology and Use in Treatment.

Sophia Giang1, Antonio La Cava2.   

Abstract

T regulatory cells (Tregs) represent a phenotypically and functionally heterogeneous group of lymphocytes that exert immunosuppressive activities on effector immune responses. Tregs play a key role in maintaining immune tolerance and homeostasis through diverse mechanisms which involve interactions with components of both the innate and adaptive immune systems. As in many autoimmune diseases, Tregs have been proposed to play a relevant role in the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease characterized by a progressive breakdown of tolerance to self-antigens and the presence of concomitant hyperactive immune responses. Here, we review how Tregs dysfunction in SLE has been manipulated experimentally and preclinically in the attempt to restore, at last in part, the immune disturbances in the disease.

Entities:  

Keywords:  Immunotherapy; Regulatory T cells; Systemic lupus erythematosus

Mesh:

Year:  2016        PMID: 27704250     DOI: 10.1007/s11926-016-0616-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  78 in total

1.  Fueling regulation: IL-2 keeps CD4+ Treg cells fit.

Authors:  Kevin J Maloy; Fiona Powrie
Journal:  Nat Immunol       Date:  2005-11       Impact factor: 25.606

2.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

3.  Increase of peripheral T regulatory cells during remission induction with cyclophosphamide in active systemic lupus erythematosus.

Authors:  Konstantinos Tselios; Alexandros Sarantopoulos; Ioannis Gkougkourelas; Aikaterini Papagianni; Panagiota Boura
Journal:  Int J Rheum Dis       Date:  2014-09       Impact factor: 2.454

4.  The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.

Authors:  Y Nozaki; T Yamagata; B-S Yoo; M Sugiyama; S Ikoma; K Kinoshita; M Funauchi; A Kanamaru
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

5.  Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.

Authors:  Hee-Kap Kang; Marissa A Michaels; Beate R Berner; Syamal K Datta
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 6.  Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.

Authors:  Stamatis-Nick C Liossis; Petros P Sfikakis
Journal:  Clin Immunol       Date:  2008-03-11       Impact factor: 3.969

7.  The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.

Authors:  Amir Sharabi; Edna Mozes
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus.

Authors:  Jesús Gómez; Catuxa Prado; Patricia López; Ana Suárez; Carmen Gutiérrez
Journal:  Clin Immunol       Date:  2009-06-21       Impact factor: 3.969

9.  Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.

Authors:  Natalia Marek-Trzonkowska; Małgorzata Myśliwiec; Anita Dobyszuk; Marcelina Grabowska; Ilona Derkowska; Jolanta Juścińska; Radosław Owczuk; Agnieszka Szadkowska; Piotr Witkowski; Wojciech Młynarski; Przemysława Jarosz-Chobot; Artur Bossowski; Janusz Siebert; Piotr Trzonkowski
Journal:  Clin Immunol       Date:  2014-04-01       Impact factor: 3.969

10.  The Treg-specific demethylated region stabilizes Foxp3 expression independently of NF-κB signaling.

Authors:  Lisa Schreiber; Beate Pietzsch; Stefan Floess; Carla Farah; Lothar Jänsch; Ingo Schmitz; Jochen Huehn
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

View more
  14 in total

1.  Distinct PLZF+CD8αα+ Unconventional T Cells Enriched in Liver Use a Cytotoxic Mechanism to Limit Autoimmunity.

Authors:  Huiming Sheng; Idania Marrero; Igor Maricic; Shaohsuan S Fanchiang; Sai Zhang; Derek B Sant'Angelo; Vipin Kumar
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

2.  Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.

Authors:  Erin B Taylor; Jennifer M Sasser; Kenji J Maeda; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

3.  Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus.

Authors:  Mengchen Guo; Huixia Wang; Sixie Xu; Yaoyao Zhuang; Jingang An; Chuan Su; Yankai Xia; Jingyun Chen; Zhenjiang Zech Xu; Qisha Liu; Jianwei Wang; Zhou Dan; Kun Chen; Xiaoting Luan; Zhi Liu; Kangjian Liu; Faming Zhang; Yumin Xia; Xingyin Liu
Journal:  Gut Microbes       Date:  2020-06-07

Review 4.  Tregs in SLE: an Update.

Authors:  Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

5.  Gut Microbiota in Systemic Lupus Erythematosus and Correlation With Diet and Clinical Manifestations.

Authors:  Xiao Wang; Qiang Shu; Lijun Song; Qi Liu; Xiaoxia Qu; Ming Li
Journal:  Front Med (Lausanne)       Date:  2022-06-30

6.  Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4+ and CD8+ Tregs That Are Functional in Humanized Mice.

Authors:  Sophia Giang; David A Horwitz; Sean Bickerton; Antonio La Cava
Journal:  Front Immunol       Date:  2021-05-26       Impact factor: 7.561

Review 7.  Regulatory T cells in renal disease.

Authors:  Maliha A Alikhan; Megan Huynh; A Richard Kitching; Joshua D Ooi
Journal:  Clin Transl Immunology       Date:  2018-01-30

Review 8.  Sex Hormones in Acquired Immunity and Autoimmune Disease.

Authors:  Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

Review 9.  Regulatory T Cells in Systemic Sclerosis.

Authors:  Camelia Frantz; Cedric Auffray; Jerome Avouac; Yannick Allanore
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

10.  Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression.

Authors:  Ricardo C Ferreira; Xaquin Castro Dopico; João J Oliveira; Daniel B Rainbow; Jennie H Yang; Dominik Trzupek; Sarah A Todd; Mhairi McNeill; Maristella Steri; Valeria Orrù; Edoardo Fiorillo; Daniel J M Crouch; Marcin L Pekalski; Francesco Cucca; Tim I Tree; Tim J Vyse; Linda S Wicker; John A Todd
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.